The first resource dedicated to providing concise summaries of the most clinically relevant inpatient care guideline summaries CURRENT Practice Guidelines in Inpatient Medicine, 2018-2019 is written to spare busy physicians, nurse practitioners, physician assistants, and medical students from having to wade through full-length practice guidelines in order to provide high-quality care for hospitalized adults. With content drawn from reliable sources such as major professional societies and government agencies, each section of the book outlines the guidelines surrounding initial assessment,…mehr
The first resource dedicated to providing concise summaries of the most clinically relevant inpatient care guideline summaries CURRENT Practice Guidelines in Inpatient Medicine, 2018-2019 is written to spare busy physicians, nurse practitioners, physician assistants, and medical students from having to wade through full-length practice guidelines in order to provide high-quality care for hospitalized adults. With content drawn from reliable sources such as major professional societies and government agencies, each section of the book outlines the guidelines surrounding initial assessment, acute management, and subsequent care for conditions commonly encountered in the hospital setting. CURRENT Practice Guidelines in Inpatient Medicine, 2018-2019 strikes the perfect balance between brevity and clinical necessity, delivering exactly the amount of information needed - no more, no less
Jacob David, MD (Ventura, CA) is Associate Program Director, Ventura County Medical Center Family Medicine Residency Program. >
Inhaltsangabe
1. Cardiovascular a. Cardiopulmonary Resuscitation b. Acute Coronary Syndrome i. Initial assessment ii. Acute medical management 1. Antiplatelet therapy 2. Beta blockers 3. Renin-angiotensin-aldosterone system inhibitors 4. Lipid-lowering agents 5. Nitrates 6. Calcium channel blockers 7. Oxygen 8. Analgesics iii. Coronary reperfusion therapy iv. Management after stabilization 1. Antiplatelet therapy 2. Beta blockers 3. Renin-angiotensin-aldosterone system inhibitors 4. Lipid-lowering agents 5. Post-ACS risk assessments c. Congestive Heart Failure i. Initial assessment 1. NT-pro-BNP 2. Echocardiography 3. ECG ii. Acute medical management 1. Diuretics 2. Nitrates iii. Interventions 1. Non-invasive ventilation 2. Cardiac resynchronization therapy 3. Mechanical assist devices iv. Management after stabilization 1. Beta blockers 2. RAAS inhibitors 3. Aldosterone antagonist 4. Hydralazine and isosorbide dinitrate 5. Implantable cardiac defibrillator d. Atrial Fibrillation i. Initial assessment ii. Acute medical management 1. Rate control 2. Rhythym control 3. Cardioversion iii. Interventions 1. Indications for pacemaker iv. Management after stabilization 1. Rate control 2. Rhythym control 3. Candidates for ablation 4. Stroke prevention a. Assessment of stroke risk & bleeding risk b. &nb sp; Anticoagulation c. Antiplatelet agents e. Supraventricular Tachycardia i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization f. Infective Endocarditis i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization g. Valvular Heart Disease i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization h. Sepsis & Septic Shock i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 2. Vascular a. Venous Thromboembolism i. Initial assessment ii. Acute medical management iii. Interventions &nbs p; iv. Management after stabilization b. Peripheral Arterial Disease i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 3. Pulmonary a. Pneumonia i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization v. Bonus section: IDSA guidelines for management of atypical infections) 1. Aspergillosis 2. Blastomycosis 3. Coccidiomycosis 4. Cryptococcus b. COPD Exacerbation i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization c. Idiopathic pulmonary fibrosis i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 4. Neurology a. Acute Ischemic Stroke &nb sp; i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization b. Acute Hemorrhagic Stroke
1. Cardiovascular a. Cardiopulmonary Resuscitation b. Acute Coronary Syndrome i. Initial assessment ii. Acute medical management 1. Antiplatelet therapy 2. Beta blockers 3. Renin-angiotensin-aldosterone system inhibitors 4. Lipid-lowering agents 5. Nitrates 6. Calcium channel blockers 7. Oxygen 8. Analgesics iii. Coronary reperfusion therapy iv. Management after stabilization 1. Antiplatelet therapy 2. Beta blockers 3. Renin-angiotensin-aldosterone system inhibitors 4. Lipid-lowering agents 5. Post-ACS risk assessments c. Congestive Heart Failure i. Initial assessment 1. NT-pro-BNP 2. Echocardiography 3. ECG ii. Acute medical management 1. Diuretics 2. Nitrates iii. Interventions 1. Non-invasive ventilation 2. Cardiac resynchronization therapy 3. Mechanical assist devices iv. Management after stabilization 1. Beta blockers 2. RAAS inhibitors 3. Aldosterone antagonist 4. Hydralazine and isosorbide dinitrate 5. Implantable cardiac defibrillator d. Atrial Fibrillation i. Initial assessment ii. Acute medical management 1. Rate control 2. Rhythym control 3. Cardioversion iii. Interventions 1. Indications for pacemaker iv. Management after stabilization 1. Rate control 2. Rhythym control 3. Candidates for ablation 4. Stroke prevention a. Assessment of stroke risk & bleeding risk b. &nb sp; Anticoagulation c. Antiplatelet agents e. Supraventricular Tachycardia i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization f. Infective Endocarditis i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization g. Valvular Heart Disease i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization h. Sepsis & Septic Shock i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 2. Vascular a. Venous Thromboembolism i. Initial assessment ii. Acute medical management iii. Interventions &nbs p; iv. Management after stabilization b. Peripheral Arterial Disease i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 3. Pulmonary a. Pneumonia i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization v. Bonus section: IDSA guidelines for management of atypical infections) 1. Aspergillosis 2. Blastomycosis 3. Coccidiomycosis 4. Cryptococcus b. COPD Exacerbation i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization c. Idiopathic pulmonary fibrosis i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization 4. Neurology a. Acute Ischemic Stroke &nb sp; i. Initial assessment ii. Acute medical management iii. Interventions iv. Management after stabilization b. Acute Hemorrhagic Stroke
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309
